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Liver transplantation has become the only curative therapy for many patients with end-
stage liver disease and/or acute liver failure. However, this therapy is always hampered by 
the extreme sensitivity of organs to ischemia-reperfusion (I/R) injury. The process of I/R 
injury combines many interrelated factors and mediators that 
produce a cascade of events ultimately leading to graft failure. During ischemia, cellular 
damage is mainly due to the breakdown of energy metabolism, leading finally to lactate 
accumulation concomitant with derangements in calcium homeostasis. After reperfusion, 
liver injury is aggravated by the generation of toxic reactive oxygen species (ROS). 
Subsequent generation of inflammatory 
mediators and accumulation of neutrophils contribute to the progression of hepatic 
damage. Consequently, experimental and clinical studies seek to prevent liver I/R injury to 
preserve organ function. 
It is well recognized that the success of liver transplantation strongly depends on the 
composition of the preservation solution. It is well known that the main goal of organ 
preservation is the maintenance of functional, biochemical, and morphological integrity of 
the graft. In situ flushing of the organs with preservation solution permits rapid cooling to 
4°C. This is main strategy to minimize ischemic injury during cold static preservation. 
These liver grafts preservation conditions determine graft viability against normothermic 
reperfusion injury, which is especially aggravated with the use of stetaotic livers. In the 
1980s, Belzer and 
Southard developed the University of Wisconsin (UW) solution that supports good graft 
function even after extended cold preservation. However, the conditions in 
which organ transplantation was practiced in the 1980s, when UW solution was first 
developed, have now changed extremely. The lack of organs for transplantation has 
obliged physicians to utilize marginal grafts, such as steatotic 
livers, which show poor tolerance against I/R injury. In addition, recent studies have 
demonstrated that UW preservation solution presents two major limitations: the presence 
of hydroxyethyl starch (HES), as an oncotic agent, can trigger red blood cell aggregation 
and the high potassium levels require a flush of the organ in the recipient before 
transplantation. Recently, the Institute Georges Lopez (IGL-1) solution has been proposed 
as an alternative to UW solution for kidney and liver transplantation. Its benefits in clinical 
and experimental transplantation seem to be due to replacement of HES with polyethylene 
glycol and a lower K_ concentration. In this review, we have focused on possible 
protective mechanisms of IGL-1 against liver cold I/R injury, especially during use of 
marginal grafts such as steatotic livers. 
 
IGL-1 PROTECTIVE MECHANISMS AGAINST LIVER I/R INJURY 
Today, there is an increasing need for solutions that afford improved protection to livers 
from marginal donors. Studies from our laboratory have demonstrated that IGL-1 is 
superior to UW solution for rat liver preservation after 24-hour cold storage. More recently, 
we showed that IGL-1 solution more efficiently protected steatotic livers against cold I/R 
injury than UW solution. Despite these beneficial effects that initially are associated with 
antioxidant effects, the protective mechanisms of IGL-1 are complex. They may include 
the involvement of several 
prosurvival molecules such as nitric oxide (NO), as well as the activation and transduction 
of various cell signaling factors, such as hypoxia inducible factor-1 alpha (HIF-1_) and 
heme oxygensase 1 (HO-1). 
 
NITRIC OXIDE  
NO, a diffusible and protective molecule, exerts vasodilatatory and antioxidant properties 
that determine fatty liver protection. The generation of NO prevents microcirculatory 
dysfunction and the exacerbated oxidative stress within fatty livers undergoing I/R. We 
have demonstrated that steatotic livers preserved in IGL-1 solution show transient 
generation of NO as a consequence of activation of the  
constitutive endothelial NO synthase (eNOS). The addition of NO inducers, such as 
trimetazidine (an anti-ischemic drug), to IGL-1 solution potentiates eNOS-derived NO, 
enhancing protection of graft livers, confirming the direct relevance of NO for graft 
preservation against cold I/R injury. NO favors the stabilization of HIF-1_ during 
reperfusion, which is generated during cold ischemia. In addition, the benefits NO are also 
associated with its capacity to counteract endothelins (ET) that originate during I/R. ET are 
potent vasoconstrictor peptides that accumulate in the vascular space of the graft during 
cold storage. A correlation was observed between the duration of cold storage and the 
degree of ET release that is responsible for reduction of sinusoidal diameter with 
subsequent microcirculatory derangements, especially in the presence of steatosis. In 
addition, the NO enhancement induced by IGL-1 can contribute to the amelioration of the 
oxygenation of hepatic tissue18 and to the prevention of the impaired microcirculation due 
to hepatocyte fat accumulation with subsequent sinusoidal space reduction. Also, we 
demonstrated that livers preserved in IGL-1 solution supplemented with insulin-like growth 
factor (IGF-1) display increased protein kinase B or AKT (PKB/AKT) phosphorylation, 
which in turn, activates eNOS and NO generation. In this study, we observed a reduced 
release of proinflammatory cytokines, such as tumor necrosis factor (TNF-_) which 
mediates the progression of liver reperfusion damage. This observation was consistent 
with accumulating 
evidence of cross talk between IGF-1 and TNF-_during I/R injury. NO generated by IGF-1 
inhibits TNF-_release, as similarly occurs in the hepatic protection induced 
by ischemic preconditioning. 
 
OXIDATIVE STRESS AND MITOCHONDRIAL INJURY 
ROS generated from both intracellular and extracellular sources during the I/R process 
determine progression of tissue injury. Liver mitochondria appear to be an important 
sources of ROS generation. Recently we demonstrated that IGL-1 was more efficient than 
UW solution to prevent lipid peroxidation associated with hepatic I/R. IGL-1 also prevented 
mitochondrial damage as evidenced 
by lower glutamate dehydrogenase (GLDH) activity levels. CYTOPROTECTIVE 
FACTORS: HIF-1_ AND HO-1 HIF-1_, a cytoprotective transcription factor, mediates 
adaptive responses to changes in tissue oxygenation such as those occurring during liver 
preservation. Indeed, recently we demonstrated that HIF-1_ was up-regulated among liver 
grafts preserved in IGL-1 solution. This overexpression of HIF-1_ during cold storage was 
increased when IGL-1 was supplemented with trimetazidine (TMZ). Under normoxic 
conditions, HIF-1_ is degraded by prolylhydroxylases.  We demonstrated that NO 
generation by the actions of TMZ and IGL-1 impair normoxic degradation of HIF-1_, thus 
contributing to its accumulation and favoring enhanced expression of other cytoprotective 
genes such as HO-1 during liver reperfusion. It is well assumed that increases in HO-1 
activity ameliorate liver graft outcomes after transplantation. In conclusion, IGL-1 protects 
liver grafts against cold I/R injury and ameliorates function among steatotic and 
nonsteatotic organs after reperfusion. 
 
